Cisplatin-mediated upregulation of Noxa was functionally important for the killing activity of this drug in other cancer cells [42], while it was not essential for cisplatin-mediated colon cancer cell sensitization to TRAIL-induced apoptosis [30]. This evidence concerns the gene TNFSF10 and malignant colon neoplasm.